InSysBio to release the new version of Cytocon DB

June 12, 2020

June 12, 2020

We are glad to announce the release of the new version of Cytocon DB The DB was significantly extended with new data due to well-coordinated workflow of Cytocon DB team and its new members. Namely, 54 diseases, 24 tissues, 42 molecules, 24 cells and 3701 concentrations were introduced. For this purpose 89 articles were reviewed within two months. Moreover, the bugs of the previous version have been fixed:

  • Now search for data with selection of two or more diseases is available.
  • Cell markers case-insensitive search by first letters in Query section was added.
  • Reset password form was corrected.

Chart: an example of visualizing publicly available data on leucocytes in blood of healthy subjects and patients suffering from various pathologies collected in Cytocon database. Leucocyte values can be compared as the values of source original units (1E9*cells/L, cells/uL, cells/mm3, Gcell/L) were converted to unified units - kcells/L.

About InSysBio

InSysBio is a Quantitative Systems Pharmacology (QSP) company located in Moscow, Russia (INSYSBIO LLC) and Edinburgh, UK (INSYSBIO UK LIMITED). InSysBio was founded in 2004 and has an extensive track record of helping pharmaceutical companies to make right decisions on the critical stages of drug research and development by application of QSP modeling. InSysBio’s innovative QSP approach has already become a part of the drug development process implemented by our strategic partners: there are more than 100 completed projects in collaboration with leaders of pharmaceutical industry. For more information about InSysBio, its solutions and services, visit